QUINTO, ILEANA
 Distribuzione geografica
Continente #
NA - Nord America 3.717
AS - Asia 2.264
EU - Europa 1.103
SA - Sud America 398
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 7.527
Nazione #
US - Stati Uniti d'America 3.578
SG - Singapore 1.094
CN - Cina 554
IT - Italia 522
BR - Brasile 315
VN - Vietnam 214
IN - India 184
DE - Germania 147
SE - Svezia 136
GB - Regno Unito 109
CA - Canada 100
FI - Finlandia 55
KR - Corea 46
HK - Hong Kong 43
MX - Messico 27
AR - Argentina 25
BD - Bangladesh 25
FR - Francia 24
NL - Olanda 20
JP - Giappone 18
EC - Ecuador 17
ZA - Sudafrica 17
ID - Indonesia 16
UA - Ucraina 15
ES - Italia 10
RU - Federazione Russa 10
PE - Perù 9
IQ - Iraq 8
PL - Polonia 8
VE - Venezuela 8
CL - Cile 7
CO - Colombia 7
CZ - Repubblica Ceca 7
IL - Israele 7
AT - Austria 6
RO - Romania 6
SA - Arabia Saudita 6
PK - Pakistan 5
PY - Paraguay 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
GR - Grecia 4
IR - Iran 4
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
PT - Portogallo 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
DZ - Algeria 3
EU - Europa 3
IE - Irlanda 3
JM - Giamaica 3
TH - Thailandia 3
TN - Tunisia 3
UZ - Uzbekistan 3
BB - Barbados 2
EE - Estonia 2
KG - Kirghizistan 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
SY - Repubblica araba siriana 2
BH - Bahrain 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
JO - Giordania 1
KW - Kuwait 1
MM - Myanmar 1
NG - Nigeria 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 7.527
Città #
San Jose 621
Dallas 420
Chandler 394
Singapore 385
Ashburn 285
Santa Clara 178
Bengaluru 140
Hefei 140
Milan 139
Lawrence 134
Princeton 134
Munich 114
Beijing 96
Catanzaro 80
Ho Chi Minh City 80
Wilmington 76
London 69
Ottawa 67
Turku 49
Chicago 47
Des Moines 45
Hanoi 43
Hong Kong 42
Boardman 41
Seattle 39
Los Angeles 35
São Paulo 26
Shanghai 24
Naples 21
Napoli 20
New York 20
Guangzhou 18
Brooklyn 16
Montreal 15
Rome 15
Taranto 15
San Francisco 14
Augusta 13
Columbus 13
Gwangjin-gu 13
Redmond 13
The Dalles 13
Shenzhen 11
Haiphong 10
Johannesburg 10
Seoul 10
Tokyo 10
Boston 9
Marano 9
Norwalk 9
Rio de Janeiro 9
Council Bluffs 8
Mexico City 8
Paris 8
Stockholm 8
Warsaw 8
Amsterdam 7
Da Nang 7
Foggia 7
Olomouc 7
Pune 7
Thái Bình 7
Xi'an 7
Buffalo 6
Gangbuk-gu 6
Hanover 6
Helsinki 6
Houston 6
Mumbai 6
Orem 6
Redwood City 6
Atlanta 5
Guayaquil 5
Hadfield 5
Jiaxing 5
Manchester 5
Phoenix 5
Toronto 5
Vienna 5
Aversa 4
Buenos Aires 4
Campinas 4
Cleveland 4
Denver 4
Dongyang 4
Edmonton 4
Fortaleza 4
Guarulhos 4
Latina 4
Lima 4
Padova 4
Quito 4
Reggio Calabria 4
Ribeirão Preto 4
Salvador 4
Timisoara 4
Turin 4
Wuhan 4
Ann Arbor 3
Arco 3
Totale 4.508
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 148
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 102
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ. 97
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 95
A novel phage display based platform for exosome diversity characterization 95
Comparative toxicity of diphenyl, diphenyl ether and some of their hydroxyderivatives 93
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 91
B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy 88
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 88
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtk-gamma 86
Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43 86
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 84
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 83
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 82
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 81
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 80
Crucial role for IBtk in the survival and maintenance of mature B cells 77
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 77
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder 76
Human immunodeficiency virus-1 Tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65 75
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 75
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 75
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 74
Cancer-associated CD43 glycoforms as target of immunotherapy 74
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 73
Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein 72
Cancer-associated CD43 glycoforms as target of immunotherapy 72
Computational analysis and in vivo validation of a microRNA encoded by the IBTK gene, a regulator of B-lymphocytes differentiation and survival 71
IkappaB-alpha Represses the Transcriptional Activity of the HIV-1 Tat Transactivator by Promoting Its Nuclear Export 71
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 71
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma 70
Inhibition of HIV-1 replication in primary human monocytes by the IkappaB-alfaS32/36A repressor of NF-kappaB 70
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 69
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 68
The aftermath of the Merck's HIV vaccine trial 67
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 67
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 67
Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein 66
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 62
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 62
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 61
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 60
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 60
High attenuation and immunogenicity of a simian immunodeficiency virus expressing a proteolysis-resistant inhibitor of NF-kappa B 59
A NF-kB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kB-activating stimuli 59
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 59
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 59
A comparative study on the toxicity and mutagenicity of biphenyl (BP) and diphenyl ether (DPE) in sea urchin, S. typhimurium and S. cerevisiae. 58
Spontaneous and mutagen-mediated amplification of a neo gene integrated at different genomic sites in Rat 2 fibroblasts 58
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 58
Molecular characterization of tumor-derived exosomes as tool for minimal residual disease monitoring 58
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 58
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 58
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 57
Mutagenicity of twelve imidazole derivatives with trichomonacide activity 57
Autocrine growth function of interleukin-1 and interleukin-6 molecules on human transformed B cells 57
Phage Display: An Overview in Context to Drug Discovery 57
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 56
Carcinogenic potency in rodents versus genotoxic potency in E. coli: a correlation analysis for bifunctional alkylating agents 56
I tests di mutagenesi nella valutazione della tossicologia dei farmaci. 56
Crucial role for IBtkgamma in the survival and maintenance of matureB cells 56
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 56
DNA damaging agents increase the stability of interleukin-1alfa, interleukin-1beta and interleukin-6 transcripts and the production of the relative proteins 56
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 56
High efficiency of site-directed mutagenesis mediated by a single PCR product 55
Phage Display: An Overview in Context to Drug Discovery 55
Partial purification and MALDI-TOF MS analysis of UN1, a tumor antigen membrane glycoprotein 55
Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors 54
Effect of DNOC, Ferbam and Imidan exposure on mouse sperm morphology 53
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 53
Epstein-Barr Virus Nuclear Antigen 2 transactivates the Long Terminal Repeat of Human Immunodeficiency Virus Type 1 52
Exosome-associated miRNAs profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 52
Aspetti generali di tossicologia genetica 51
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 51
Ultraviolet Mutagenesis 51
Expression of an exogenous interleukin-6 gene in human EBV-B cells confers growth advantage and in vivo tumorigenicity 50
Regulation of the HIV Promoter/Enhancer 50
Insights into Thymus Development and Viral Thymic Infections 50
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 49
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 49
Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle 48
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 48
Structural and functional insights into IκB-α/HIV-1 Tat interaction. 47
Metodo di attenuazione stabile di retrovirus HIV-1 e SIV per acquisizione di funzione: sviluppo di un virus vaccino attenuato per l'AIDS 47
Genotoxicity and teratogenicity of diphenyl and diphenyl ether: a study of sea urchins, yeast, and Salmonella typhimurium 47
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 47
Screening of 24 pesticides by Salmonella/microsome assay: mutagenicity of benazolin, metoxuron and paraoxon. 46
Frameshift mutagenicity of furocoumarins in the dark 46
Multimodal Imaging for a Theranostic Approach in a Murine Model of B-cell Lymphoma with Engineered Nanoparticles 46
Impaired generation of bone marrow B-lymphocytes in mice deficient in C/EBP beta 45
Further validation of the E. coli multitest: in vitro and in vivo metabolic activation of procarcinogens 45
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 44
Mutagenic epoxide impurities discovered in two beta-adrenergic blocking agents 44
Molecular modeling of epitopes recognized by neoplastic B-cells in Chronic Lymphocytic Leukemia 44
Frameshift mutagenesis in the dark of furocoumarins proposed for photochemotherapy 43
Sperm abnormalities in mice exposed to diesel particulate 43
Perspectives for a Protective HIV-1 Vaccine in "HIV-1: Molecular Biology and Pathogenesis" 43
Peptide-guided targeting of GPR55 for anti-cancer therapy. 43
MUTAGENS ENHANCE THE HIV-1, INTERLEUKIN-1 (IL-1), AND INTERLEUKIN-6 (IL-6) EXPRESSION THROUGH TRANSCRIPTIONAL OR POSTTRANSCRIPTIONAL MECHANISMS 42
Polypeptide capable of inhibiting HIV-1 transcription and replication and uses thereof 42
Totale 6.295
Categoria #
all - tutte 72.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.391


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022464 9 9 7 111 27 10 21 130 29 50 58 3
2022/20231.175 270 35 62 67 126 95 7 114 227 68 80 24
2023/2024477 98 60 60 25 28 116 3 15 6 7 19 40
2024/20251.693 242 96 93 56 136 186 26 46 245 93 185 289
2025/20263.432 197 381 566 490 332 159 400 206 366 194 97 44
2026/202725 25 0 0 0 0 0 0 0 0 0 0 0
Totale 7.649